(Press-News.org) Each year, the ACMG Foundation for Genetic and Genomic Medicine grants its Next Generation Fellowship awards to promising early career professionals in a range of medical genetics and genomics specialties including Clinical Genetics, Clinical Biochemical Genetics, Laboratory Genetics and Genomics, Medical Biochemical Genetics and Ophthalmic Genetics. Support for this year’s class of fellows was generously provided by Bionano, Pfizer, Sanofi, Spark Therapeutics, and Takeda. The ACMG Foundation depends on corporate donations to support these and many other critical programs and thanks all the members of our Corporate Partners Program.
“These four recipients of the 2025 ACMG Foundation Next Generation fellowship awards truly exemplify the future of our field. These clinician scientists are the best and the brightest, and are doing work that is making significant impact, moving the field of genomics to the next level. I am indebted to their work ethic and enthusiasm,” said Nancy J. Mendelsohn, MD, FACMG, president of the ACMG Foundation.
Clinical Biochemical Genetics Fellowship Award:
Rafael Garrett da Costa, PhD
Rafael Garrett da Costa, PhD, is currently a Senior Staff Scientist at the Department of Laboratory Medicine, Boston Children’s Hospital, Harvard Medical School. He holds a BSc in Pharmacy as well as an MSc and PhD in Chemistry from the Federal University of Rio de Janeiro, Brazil. With a background in mass spectrometry and metabolomics, he developed a passion for investigating rare metabolic disorders and developing new methods for laboratory diagnosis. Over the course of his career, Dr. Garrett da Costa has authored more than 60 peer-reviewed publications, contributed to two book chapters, filed three patent applications and mentored several students. For the past five years, his work has focused on inborn errors of metabolism, aiming to bridge innovative diagnostic approaches with patient care.
“I am truly honored and excited to receive the Next Generation Fellowship and Training Award from the ACMG Foundation. This award offers a unique opportunity for me to deepen my knowledge in clinical biochemical genetics. I am committed to translating this experience into better patient testing and care,” said Dr. Garrett da Costa.
Laboratory Genetics and Genomics Fellowship Award:
Atlas Sardoo, PhD, National Institutes of Health
Atlas Sardoo, PhD is a scientist at the National Institutes of Health (NIH) specializing in Next-Generation Sequencing (NGS) and translational research. With a PhD in Human Genetics, her work focuses on understanding the role of viral infections in liver cancer and developing risk prediction models. Passionate about bridging bioinformatics and clinical diagnostics, Dr. Sardoo is preparing to pursue the Laboratory Genetics and Genomics Fellowship to apply her expertise to genetic testing and patient care.
Upon receiving the award, Dr. Sardoo said, “I am deeply honored to receive the Next Generation Award. This recognition motivates me to continue advancing my work in clinical genetics and to make meaningful contributions to patient care through genomic research.”
Ophthalmic Genetics Specialty Fellowship Award:
Emily S. Levine, MD, MTM, Casey Eye Institute at Oregon Health and Science University
Dr. Levine received her BA in Biology with a minor in computer science from Bryn Mawr College in 2012, graduating magna cum laude with departmental honors. She spent several years working in a retinal physiology lab at the University of California Davis before pursuing a Masters in Translational Medicine at UC Berkeley/UCSF. Dr. Levine subsequently earned her medical degree with research honors from Tufts University School of Medicine, during which she dedicated an additional research year as the Optical Coherence Tomography Research Fellow at the New England Eye Center. Dr. Levine currently serves as a chief ophthalmology resident at Dartmouth Hitchcock Medical Center. She will begin a clinical fellowship in ophthalmic genetics at the Casey Eye Institute of Oregon Health and Science University in Portland, OR this summer.
“It is an immeasurable honor to receive the Next Generation Award and serve families affected by genetic eye conditions,” said Dr. Levine.
Medical Biochemical Genetics Subspecialty Fellowship Award:
Daniel R. Brooks, MD, Baylor College of Medicine
Dr. Daniel R. Brooks is currently a resident in the combined Pediatrics/Medical Genetics and Genomics program at Baylor College of Medicine/Texas Children’s Hospital, where he combines clinical expertise with a passion for patient advocacy and ensuring equitable healthcare delivery. He earned his MD from the University of Michigan Medical School and completed his undergraduate degree in Biology at the University of Pennsylvania.
His contributions span research on prenatal genetic diagnostics, rare disease identification and expanding genetic services to underserved populations. Dr. Brooks has co-authored numerous peer-reviewed publications, with work featured in journals such as Human Genetics and Prenatal Diagnosis. His role in the NIH-funded Project GIVE highlights his dedication to addressing healthcare disparities by using telehealth to provide genetic testing to underserved Hispanic communities in the Rio Grande Valley.
Dr. Brooks has received multiple honors, including the NIH Biomedical Research Training Grant and a Fulbright Fellowship, recognizing his commitment to advancing genetic medicine and improving patient outcomes. He is grateful for the ACMGF Next Generation Fellowship award and looks forward to continuing his training in Medical Biochemical Genetics and advancing his career goals.
"I am grateful for the ACMGF Next Generation Fellowship award and the opportunity to be recognized among such distinguished peers. My work is rooted in the belief that genetic medicine should be accessible to everyone, not just a privileged few. This recognition reaffirms my mission to bridge diagnostic gaps and bring the benefits of genomic advances in inborn errors of metabolism to underserved communities," said Dr. Brooks about receiving the award.
About the ACMG Foundation for Genetic and Genomic Medicine
The ACMG Foundation for Genetic and Genomic Medicine, a 501(c)(3) nonprofit organization, is a community of supporters and contributors who understand the importance of medical genetics and genomics in healthcare. Established in 1992, the ACMG Foundation supports the American College of Medical Genetics and Genomics (ACMG) mission to “translate genes into health.” Through its work, the ACMG Foundation fosters charitable giving, promotes training opportunities to attract future medical geneticists and genetic counselors to the field, shares information about medical genetics and genomics, and sponsors important research. To learn more and support the ACMG Foundation mission to create “Better Health through Genetics” visit acmgfoundation.org.
Note to editors: To arrange interviews with experts in medical genetics, contact ACMG Communications Manager, Barry Eisenberg, MS at beisenberg@acmg.net.
END
The ACMG Foundation for Genetic and Genomic Medicine presents four next generation Fellowship Awards at the 2025 ACMG Annual Clinical Genetics Meeting
2025-03-19
ELSE PRESS RELEASES FROM THIS DATE:
Marine animals help solve ocean issues
2025-03-19
Sensors attached to animals gather valuable data to track and mitigate the human influence on marine life. The Kobe University review paper emphasizes the importance of integrating data from various sources and advocates for an “Internet of Animals” based on open access and shared standards.
Humanity influences marine life through a broad range of activities, spanning from fishing and pollution to noise from boats, construction and mining. To enable a sustainable life together, we need to monitor the influence of our activities on marine life and use this ...
CNT wires for wearable electronic devices from the existing fiber manufacturing process!
2025-03-19
Dr. Han Joong Tark's team at KERI's Nano Hybrid Technology Research Center has successfully fabricated ‘functional wires’, which are the foundation of wearable electronic devices, by directly applying the existing synthetic fiber processing methods.
Wearable electronic devices, which can be attached to or worn on the body, such as on the wrist, ear, or eyes, have long become a part of our daily lives in various forms like smartwatches, glasses, and earphones. The key to these devices is that they must be lightweight while maintaining long-lasting performance. While there have been various efforts to achieve this, one of the most important elements is the conductive ...
Researchers reveal role of zeolite zcid site accessibility in syngas conversion
2025-03-19
Zeolites and zeotypes are widely used in the energy and chemical industries due to their unique pore structures and excellent shape-selective catalytic properties. However, these inherent advantages also lead to diffusion limitations, preventing guest molecules from effectively accessing internal active sites and thereby hindering catalytic efficiency.
In a study published in Angewandte Chemie International Edition, a research group led by Prof. JIAO Feng and Prof. PAN Xiulian from the Dalian Institute of Chemical Physics (DICP) of the Chinese Academy of Sciences has revealed how the accessibility of ...
Gender gap in teenage depression is twice as large in London than in Tokyo, new study finds
2025-03-19
Published in The Lancet Child & Adolescent Health, the study aimed to provide robust insights into adolescent mental health trajectories in two different cultural contexts by comparing large samples of 11 to 16 years olds in London and Tokyo over time. The two studies are the Tokyo Teen Cohort (TTC) and the Resilience Ethnicity and AdolesCent Mental Health (REACH) cohorts from South London. Both groups collected data in the period 2014 to 2020 and at three different time points as the teenagers grew older.
Researchers used the Short Mood and Feelings ...
Coffee-making robot breaks new ground for AI machines
2025-03-19
An AI-powered robot that can prepare cups of coffee in a busy kitchen could usher in the next generation of intelligent machines, a study suggests.
Using a combination of cutting-edge AI, sensitive sensors and fine-tuned motor skills, the robot can interact with its surroundings in more human-like ways than ever before, researchers say.
The new technology, developed by a team at the University of Edinburgh, could transform robots’ ability to carry out tasks that previously could only be done by people.
While robots are adept at working in tightly controlled settings such as factories ...
Protecting crops: Researchers open up new avenue to combat a widespread plant virus
2025-03-19
New RNA-based active agents reliably protect plants against the Cucumber mosaic virus (CMV), the most common virus in agriculture and horticulture. They were developed by researchers at the Martin Luther University Halle-Wittenberg (MLU). The active ingredients have a broad spectrum effect; a series of RNA molecules support the plant's immune system in combating the virus. In laboratory experiments, 80 to 100 per cent of the treated plants survived an infection with a high viral load, as the team reports in Nucleic Acids Research. Their paper has been selected as a "breakthrough article" by the journal. The researchers are now working ...
UCLA discovers first stroke rehabilitation drug to repair brain damage
2025-03-18
A new study by UCLA Health has discovered what researchers say is the first drug to fully reproduce the effects of physical stroke rehabilitation in model mice, following from human studies.
The findings, published in Nature Communications, tested two candidate drugs derived from their studies on the mechanism of the brain effects of rehabilitation, of which one resulted in significant recovery in movement control after stroke in the mouse model.
Stroke is the leading cause of adult disability because most patients do not fully recover from the effects of stroke. There are no drugs in the field of stroke ...
Only around 1 in 10 common non-surgical and non-invasive treatments for back pain effective
2025-03-18
Only around 1 in 10 common non-surgical and non-invasive treatments for lower back pain is effective, suggests a pooled data analysis of the available research, published online in BMJ Evidence Based Medicine.
And the pain relief they offer is only marginally better than that achieved with a placebo, the findings indicate.
Low back pain is common and debilitating, and 80%-90% of it is categorised as non-specific, because there’s no immediately identifiable cause, note the researchers.
Non-surgical and non-invasive ...
Installing safety nets on Golden Gate Bridge linked to 73% decline in suicides
2025-03-18
Early evidence indicates that the installation of safety nets on the Golden Gate Bridge in San Francisco has been successful in reducing the number of suicides at the bridge.
The results, published online in the journal Injury Prevention, show a 73% decline in suicides in the 12 months since the nets were completed relative to the number before net installation began.
The researchers say their findings “highlight the value of installing nets on this bridge and the importance of barriers as a strategy to prevent suicides by jumping.”
The ...
Increasing fruit, fiber, dairy and caffeine linked to lower risk of tinnitus
2025-03-18
Increased consumption of fruit, dietary fibre, dairy products and caffeine may be associated with a reduced risk of tinnitus (ringing in the ears), suggests an analysis of the available evidence, published in the open access journal BMJ Open.
The researchers stress that their findings can’t establish a direct (causal) relationship and should be interpreted with care because of the low quality of the evidence. But they say possible reasons may involve the protective effects of these diets on blood vessels and nerves, as well as their anti-inflammatory ...